These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16446437)

  • 1. Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease.
    Guo JP; Arai T; Miklossy J; McGeer PL
    Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1953-8. PubMed ID: 16446437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.
    Zhang H; Wei W; Zhao M; Ma L; Jiang X; Pei H; Cao Y; Li H
    Int J Biol Sci; 2021; 17(9):2181-2192. PubMed ID: 34239348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive temporal profiles of detergent-soluble and -insoluble tau and Aβ species in human Alzheimer's disease.
    Koss DJ; Dubini M; Buchanan H; Hull C; Platt B
    Brain Res; 2018 Nov; 1699():121-134. PubMed ID: 30102892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain.
    Horie K; Barthélemy NR; Mallipeddi N; Li Y; Franklin EE; Perrin RJ; Bateman RJ; Sato C
    Acta Neuropathol Commun; 2020 Aug; 8(1):149. PubMed ID: 32854776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.
    Mukherjee S; Dubois C; Perez K; Varghese S; Birchall IE; Leckey M; Davydova N; McLean C; Nisbet RM; Roberts BR; Li QX; Masters CL; Streltsov VA
    J Neurochem; 2023 Feb; 164(4):529-552. PubMed ID: 36271678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.
    Kawarabayashi T; Shoji M; Younkin LH; Wen-Lang L; Dickson DW; Murakami T; Matsubara E; Abe K; Ashe KH; Younkin SG
    J Neurosci; 2004 Apr; 24(15):3801-9. PubMed ID: 15084661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of soluble, synaptotoxic amyloid β species by antibodies is epitope specific.
    Zago W; Buttini M; Comery TA; Nishioka C; Gardai SJ; Seubert P; Games D; Bard F; Schenk D; Kinney GG
    J Neurosci; 2012 Feb; 32(8):2696-702. PubMed ID: 22357853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease.
    Tremblay C; Pilote M; Phivilay A; Emond V; Bennett DA; Calon F
    J Alzheimers Dis; 2007 Dec; 12(4):377-90. PubMed ID: 18198424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway.
    Tokutake T; Kasuga K; Yajima R; Sekine Y; Tezuka T; Nishizawa M; Ikeuchi T
    J Biol Chem; 2012 Oct; 287(42):35222-35233. PubMed ID: 22910909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.
    Tran HT; LaFerla FM; Holtzman DM; Brody DL
    J Neurosci; 2011 Jun; 31(26):9513-25. PubMed ID: 21715616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected.
    Suárez-Calvet M; Karikari TK; Ashton NJ; Lantero Rodríguez J; Milà-Alomà M; Gispert JD; Salvadó G; Minguillon C; Fauria K; Shekari M; Grau-Rivera O; Arenaza-Urquijo EM; Sala-Vila A; Sánchez-Benavides G; González-de-Echávarri JM; Kollmorgen G; Stoops E; Vanmechelen E; Zetterberg H; Blennow K; Molinuevo JL;
    EMBO Mol Med; 2020 Dec; 12(12):e12921. PubMed ID: 33169916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C; Kulic L; Nitsch RM
    PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II.
    Rank KB; Pauley AM; Bhattacharya K; Wang Z; Evans DB; Fleck TJ; Johnston JA; Sharma SK
    FEBS Lett; 2002 Mar; 514(2-3):263-8. PubMed ID: 11943163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.